Journal of Cancer Prevention 2015; 20(1): 25-40
Published online March 30, 2015
© Korean Society of Cancer Prevention
Yo Han Park1, and Nayoung Kim1,2
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
Correspondence to :
Nayoung Kim, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-mail: firstname.lastname@example.org, ORCID: Nayoung Kim, http://orcid.org/0000-0002-9397-0406
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Atrophic gastritis (AG) and intestinal metaplasia (IM) are the main precursor lesions of gastric cancer as the incidence of gastric cancer increases in the gastric mucosa involved with AG and IM. The prevalence of AG and IM vary depending on countries, even it represents diverse results in the same nation. Usually AG is antecedent of IM but the etiologies of AG and IM are not always the same. The sensitivity and specificity of diagnostic methods to detect AG and IM are different. Furthermore, the management strategy of AG and IM has not been established, yet.
Keywords: Atrophic gastritis,
Jung Won Lee, Nayoung Kim, Ji Hyun Park, Hee Jin Kim, Hyun Chang, Jung Min Kim, Jin-Wook Kim, and Dong Ho LeeJournal of Cancer Prevention 2017; 22(1): 33-39 https://doi.org/10.15430/JCP.2017.22.1.33
Hye-Kyung Na, and Jeong-Hwa WooJournal of Cancer Prevention 2014; 19(4): 259-264 https://doi.org/10.15430/JCP.2014.19.4.259
Da-Young Lee, Moon-Young Song, Eun-Hee KimJ Cancer Prev 2021; 26(2): 137-144 https://doi.org/10.15430/JCP.2021.26.2.137